Transcriptional regulation is crucial for liver function. Both ligand-activated nuclear receptors (NRs) and orphan nuclear receptors (ONRs, NRs without known endogenous ligands) are important transcription factors to regulate gene transcription in the liver. Farnesoid X receptor (FXR) is a ligand-activated NR and bile acids are endogenous ligands of FXR. The homeostasis of bile acids is important for liver health because in addition to providing a major route for cholesterol removal bile acids also activate FXR, G-protein coupled receptor, and other signaling pathways. Emerging evidence highly supports the role of FXR in regulating broader liver homeostasis. Clearly, FXR is important for liver function because FXR deficiency in mice causes cholestasis, dyslipidemia, gallstone, hepatocellular carcinoma and diabetes. However, a major gap exists in understanding how FXR regulates transcription during liver homeostasis, which prevents us from understanding the roles of FXR in development and progression of these diseases. In order to translate FXR function in human liver physiology and diseases, it is important to determine the extent of species similarities in FXR regulation, since most studies have only been completed in mice. My hypothesis is that FXR interacts with both NRs and ONRs to regulate species-conserved pathways in the liver. My hypothesis is that ONRs facilitate chromatin modification for subsequent FXR binding and FXR interaction with HNF4α is crucial in orchestrating transcription of target genes critical for liver function. This hypothesis will be tested in three specific aims. (1) Test the importance of ONRs in establishing a permissive chromatin environment for subsequent FXR binding to target genes. (2) Test the hypothesis that HNF4α and FXR work together by coordinately regulating transcription of their target genes. (3) Determine similarities in FXR target genes and regulated pathways in liver of mice and humans. The proposed research is innovative in understanding transcriptional mechanism by which FXR collaborates with other transcription factors to maintain liver homeostasis. At the completion of these studies, we expect to provide a mechanism, at the chromatin level, by which liver FXR, ONRs, and HNF4 α coordinately regulate gene transcription in liver. In addition, we expect to elucidate the species similarities and differences between mice and humans for the FXR target genes and regulated pathways in the liver. The species similarities will provide a scientific basis for selection of relevant translational research of FXR in human liver physiology and diseases.

Public Health Relevance

Farnesoid X receptor (FXR) is very important for the liver and intestine health. FXR is a transcription factor and belongs to the nuclear receptor superfamily and is important in maintaining the homeostasis of bile acids, cholesterol, fatty acids, and glucose in the liver. Deficiency of FXR in mice results in many diseases that are common in humans, including nonalcoholic steatohepatitis, cholestasis, gall stones, hepatocellular carcinoma, colitis and colon cancer. Modulating FXR function may prevent and/or treat bile acid- and/or lipid-related diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56DK090036-01A1
Application #
8328025
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Karp, Robert W
Project Start
2011-09-26
Project End
2013-08-31
Budget Start
2011-09-26
Budget End
2013-08-31
Support Year
1
Fiscal Year
2011
Total Cost
$328,425
Indirect Cost
Name
University of Kansas
Department
Pharmacology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Schumacher, J D; Kong, B; Pan, Y et al. (2017) The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis. Toxicol Appl Pharmacol 330:1-8
Chow, Monica D; Lee, Yi-Horng; Guo, Grace L (2017) The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mol Aspects Med 56:34-44
Armstrong, Laura E; Guo, Grace L (2017) Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis. Curr Pharmacol Rep 3:92-100
Schumacher, Justin D; Guo, Grace L (2015) Mechanistic review of drug-induced steatohepatitis. Toxicol Appl Pharmacol 289:40-7
Schmitt, Johannes; Kong, Bo; Stieger, Bruno et al. (2015) Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal. Liver Int 35:1133-1144
Zhan, Le; Liu, Hui-Xin; Fang, Yaping et al. (2014) Genome-wide binding and transcriptome analysis of human farnesoid X receptor in primary human hepatocytes. PLoS One 9:e105930
Bailey, Ann M; Zhan, Le; Maru, Dipen et al. (2014) FXR silencing in human colon cancer by DNA methylation and KRAS signaling. Am J Physiol Gastrointest Liver Physiol 306:G48-58
Kong, Bo; Huang, Jiansheng; Zhu, Yan et al. (2014) Fibroblast growth factor 15 deficiency impairs liver regeneration in mice. Am J Physiol Gastrointest Liver Physiol 306:G893-902
Kong, Bo; Guo, Grace L (2014) Soluble expression of disulfide bond containing proteins FGF15 and FGF19 in the cytoplasm of Escherichia coli. PLoS One 9:e85890
Manley, Sharon; Ni, Hong-Min; Kong, Bo et al. (2014) Suppression of autophagic flux by bile acids in hepatocytes. Toxicol Sci 137:478-90

Showing the most recent 10 out of 18 publications